Department of Clinical Toxicology, Saitama Medical University, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama, 355-0495, Japan; Department of Critical Care Medicine and Trauma, National Hospital Organization Disaster Medical Center, 3256 Midoricho, Tachikawa, Tokyo, 190-0014, Japan.
Department of Clinical Toxicology, Saitama Medical University, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama, 355-0495, Japan.
Am J Emerg Med. 2023 Oct;72:221.e5-221.e7. doi: 10.1016/j.ajem.2023.08.034. Epub 2023 Aug 22.
Phenobarbital poisoning, which may cause circulatory collapse as well as respiratory arrest in severe cases, has one of the highest mortality rates among acute drug poisonings. A 58-year-old man arrived at the emergency room in a deep coma (Glasgow Coma Scale E1V1M1) after taking an unknown dose of phenobarbital which had been prescribed for his cat's seizures. Venous blood gas analysis revealed hypercapnia (PvCO: 113.0 mmHg) and a blood phenobarbital concentration of 197.3 μg/mL. Shortly after his arrival, respiratory arrest and circulatory collapse occurred. Mechanical ventilation after intubation, intravenous noradrenaline infusion, and multiple-dose activated charcoal through a nasogastric tube was started. Six hours after arrival, blood phenobarbital concentration was abnormally elevated to 356.8 μg/mL with circulatory collapse requiring an increased dose of intravenous noradrenaline infusion (up to 0.13 μg/kg/min). Continuous renal replacement therapy including high flow continuous hemodialysis was performed until hospital day 5, during which blood phenobarbital concentration decreased to 96.2 μg/mL on hospital day 4, resulting in a sufficient resumption of spontaneous breathing and full improvement of circulatory collapse. A search of the literature revealed that the peak phenobarbital concentration in the present case exceeded those of fatal cases, as well as those of survivors of acute phenobarbital poisoning. However, the patient was successfully treated with continuous renal replacement therapy. Among modalities of extracorporeal treatment, continuous renal replacement therapy could be considered if a patient's circulation is unstable.
苯巴比妥中毒可导致严重病例发生循环衰竭和呼吸停止,在急性药物中毒中死亡率最高之一。一名 58 岁男子因服用未知剂量的苯巴比妥(用于治疗他的猫的癫痫发作)而陷入深度昏迷(格拉斯哥昏迷量表 E1V1M1),被紧急送往急诊室。静脉血气分析显示高碳酸血症(PvCO:113.0mmHg)和血液苯巴比妥浓度为 197.3μg/mL。他到达后不久,出现呼吸停止和循环衰竭。随后立即进行气管插管机械通气、静脉去甲肾上腺素输注和多次通过鼻胃管给予活性炭。到达后 6 小时,血液苯巴比妥浓度异常升高至 356.8μg/mL,同时循环衰竭需要增加静脉去甲肾上腺素输注剂量(高达 0.13μg/kg/min)。持续肾脏替代治疗,包括高流量连续血液透析,持续至入院第 5 天,在此期间,入院第 4 天血液苯巴比妥浓度降至 96.2μg/mL,患者自主呼吸恢复良好,循环衰竭完全改善。文献检索显示,本例患者的苯巴比妥峰值浓度超过了致命病例以及急性苯巴比妥中毒幸存者的浓度。然而,该患者通过持续肾脏替代治疗成功治疗。在体外治疗方式中,如果患者的循环不稳定,可以考虑使用持续肾脏替代治疗。